advances and challenges in targeting kinases in cancer therapeutics
Published 1 year ago • 79 plays • Length 47:59Download video MP4
Download video MP3
Similar videos
-
48:30
advances and challenges in targeting kinases in cancer therapeutics
-
44:25
targeted cancer therapy: choosing the right assay to assess parp inhibitors
-
1:27:51
webinar - protacs and their application in cancer therapeutics
-
15:56
molecular tests for targeted therapies in advanced nsclc
-
3:41
combining jak, pim kinase and cdk4/6 inhibition in mpns
-
4:30
molecular testing guideline for patients
-
37:39
outlier kinases as targets for precision therapy
-
2:27
choosing among tkis in advanced kidney cancer
-
3:23
kinase target engagement in live cells in 3d micro-scaffolds: dr gary allenby, aurelia bioscience
-
37:38
human protein kinase ck2 inhibitors: discovering new scaffolds
-
54:23
role of cdk inhibitors in the treatment of advanced breast cancer
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
4:38
emerging checkpoint inhibitors for hnscc
-
7:11
practical challenges in switching to cdk4/6 inhibitors
-
10:57
molecular clues help refine kinase inhibitor strategy for gi
-
20:19
expert discussion on cdk 4/6 inhibition in breast cancer
-
2:59
treatment after progression on osimertinib for egfr nsclc
-
3:59
understanding tropomyosin receptor kinase inhibitors